Konica Minolta (4902) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Feb, 2026Executive summary
Revenue for the nine months ended December 31, 2025, decreased 6.1% year-over-year to ¥781.1 billion, mainly due to business selection, concentration, and lower office and healthcare sales, partially offset by growth in sensing and optical components.
Operating profit improved significantly to ¥33.3 billion from a loss of ¥18.5 billion in the prior year, driven by the absence of impairment losses, structural reform costs, and gains on sales of subsidiaries.
Profit attributable to owners rose to ¥21.4 billion from a loss of ¥13.4 billion, aided by improved finance income, tax rates, profit from discontinued operations, and a valuation gain on Tempus AI shares.
Free cash flow increased to ¥24.9 billion, reflecting higher profit before tax and asset sales.
Financial highlights
Gross profit margin rose 0.6pt to 44.4% year-over-year, despite a 4.8% decline in gross profit.
SG&A expenses fell 7% due to global structural reforms and business selection.
Business contribution profit increased 20.5% to ¥34.7 billion, with a margin improvement of 0.9 points.
Operating profit margin improved to 4.3% from negative in the prior year.
EPS turned positive at ¥43.38, up from a loss of ¥27.09.
Outlook and guidance
FY2025 full-year revenue forecast revised upward to ¥1,075.0 billion, reflecting 9M results and FOREX trends.
Operating profit forecast maintained at ¥48.0 billion; business contribution profit at ¥54.0 billion.
Dividend forecast unchanged at ¥10 per share; ROE projected at 5.2%.
Segment forecasts: Digital Workplace revenue raised to ¥598.0 billion, Professional Print to ¥250.0 billion, Industry to ¥129.0 billion, Imaging Solutions to ¥98.0 billion.
Assumptions for exchange rates updated to ¥150/USD and ¥172/EUR.
Latest events from Konica Minolta
- Operating profit surged to ¥23.0B despite 8% revenue drop, led by cost reforms and segment gains.4902
Q2 20265 Nov 2025 - Profit and margins improved despite revenue drop, cost cuts, and tariff and currency headwinds.4902
Q1 202631 Jul 2025 - Business profit up, operating loss on restructuring; Ambry sale to yield ¥41B gain.4902
Q2 202513 Jun 2025 - Revenue up 7.4% year-over-year, with improved profits and all segments growing.4902
Q1 202513 Jun 2025 - Impairments drove a sharp loss, but profit recovery and higher dividends are forecast.4902
Q4 20256 Jun 2025 - Profit growth outweighed by impairment losses and restructuring, with outlook unchanged.4902
Q3 20255 Jun 2025